Use of an immune functional assay to differentiate recurrent hepatitis C from acute cellular rejection in liver transplant patients

Liver Transplantation

Volumn 15, Issue 9, 2009, Pages 1157-

  Rubinas, Tara ^a   Dellon, Evan ^a   Henel, Gabriella ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; HEPATITIS C; HUMAN; IMMUNE FUNCTION TEST; IMMUNOASSAY; LETTER; LIVER BIOPSY; LIVER NECROSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ACUTE DISEASE; DIAGNOSIS, DIFFERENTIAL; GRAFT REJECTION; HEPATITIS C, CHRONIC; HUMANS; IMMUNOASSAY; LIVER TRANSPLANTATION; LYMPHOCYTES; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70350524718     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21774     Document Type: Letter

References (3)

1. Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan J, Firpi R, et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl 2009;15:216-222.
2. Batts KP, Ludwig J. Chronic hepatitis, an update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
3. Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, et al. Reliability of histopathologic assessment of the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 2004;10:1233-1239. (Pubitemid 39406076)